Analysis: Failed Alzheimer's drug may get second chance
14:41 EDT 7 Aug 2012 | Reuters
CHICAGO (Reuters) - Pfizer and Johnson & Johnson's Alzheimer's drug failed to help patients showing early signs of the disease, but it could get another chance as scientists test whether the devastating illness should be treated before symptoms appea..
Original Article: Analysis: Failed Alzheimer's drug may get second chance
More From BioPortfolio on "Analysis: Failed Alzheimer's drug may get second chance"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
